Open Label Study to Evaluate the Safety and Efficacy of AK101 Injection Subcutaneously in Subjects With Psoriasis

NCT05509361 · clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
950
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Akeso